Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in 131I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 4, 2005, Pages 458-469

  Boucek, Jan A ^a   Turner, J Harvey ^a,b  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dosimetry; Non Hodgkin's lymphoma; Radioimmunotherapy; Rituximab; SPECT CT

Indexed keywords

IODINE 131; RITUXIMAB;

ADULT; AGED; ARTICLE; BODY WEIGHT; BONE MARROW; BONE MARROW TOXICITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSIMETRY; DRUG HALF LIFE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOIMMUNOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BODY BURDEN; BONE MARROW; FEMALE; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RADIATION INJURIES; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WHOLE-BODY COUNTING;

EID: 17844390711     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1692-9     Document Type: Article

References (21)

1. 131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma: a phase II clinical trial of a non-myeloablative dose regimen of chimeric rituximab radiolabeled in a hospital. Cancer Biother Radiopharm 2003;18:513-24.
2. Wahl RL. Iodine-131 anti-B1 antibody therapy in non-Hodgkin's lymphoma: dosimetry and clinical implications. J Nucl Med 1998;39(suppl):1S-9S.
3. Wahl RL, Kroll S, Zasadny KR. Patient-specific whole-body dosimetry: principles and a simplified method for clinical implementation. J Nucl Med 1998;39(suppl):9S-16S.
4. Wiseman GA, Leigh B, Lamonica D, Kommehl E, Spies SM, Silverman DHS, et al. Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma. Cancer 2002;94:1349-57.
5. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumour regression in patients with lymphoma. J Nucl Med 1999;40:303-10
6. Turner JH, Martindale AA, Sorby P. Hetherington EL, Fleay R, Hoffman R, et al. Samarium-153 EDTMP therapy of disseminated skeletal metastasis. Eur J Nucl Med 1989;15:784-95.
7. 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma. Blood 2004;104:642 -8.
8. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med 1993;34:689-94.
9. Macey DJ, DeNardo SJ, DeNardo GL, DeNardo DA, Shen S. Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy. Clin Nucl Med 1995;20:117-25.
10. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538-46.
11. Bouchet LG, Bolch WE, Howell RW, Rao DV. S values for radionuclides localized within the skeleton. J Nucl Med 2000;41:189-212.
12. Bolch WE, Patton PW, Rajon DA, Shah AP, Jokisch DW, Inglis BA. Considerations of marrow cellularity in 3-dimensional dosimetric models of the trabecular skeleton. J Nucl Med 2002;43:97-108.
13. Stabin MG, Eckerman KF, Bolch WE, Bouchet LG, Patton PW. Evolution and status of bone and marrow dose models. Cancer Biother Radiopharm 2002;17:427-33.
14. Coffey JL, Watson EE. Calculating dose from remaining body activity: a comparison of two methods. Med Phys 1979;6:307-8.
15. 90Y- ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from four clinical trials. J Nucl Med 2003;44:465-74.
16. Snyder WS et al. Report of the task group on reference man. Pergamon Press, ICRP report No.23. Oxford, UK: International Commission on Radiological Protection; 1974.
17. Juweid ME. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med 2002;43:1507-29.
18. ICRP 70, Basic anatomical and physiological data for use in radiological protection: the skeleton. ICRP publication 70. Oxford, UK: International Commission on Radiological Protection; 1995.
19. Patton JA, Delbeke D, Sandler MP. Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. J Nucl Med 2000;41:1364-68.
20. Knoos T, Nilsson M, Ahlgren L. A method for conversion of Hounsfield number to electron density and prediction of macroscopic pair production cross-sections. Radiother Oncol 1986;5:337-45.
21. Duck FA. Physical properties of tissue: a comprehensive reference book. New York: Academic Press; 1990.